Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081294 | SCV000113202 | benign | not specified | 2013-04-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081294 | SCV000517591 | benign | not specified | 2015-12-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001514858 | SCV001722809 | benign | Methylmalonic acidemia with homocystinuria, type cblX | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001514858 | SCV001934090 | benign | Methylmalonic acidemia with homocystinuria, type cblX | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004713244 | SCV005275013 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000081294 | SCV000151385 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |